Europe Dermatological Drugs Market Size & Outlook
Europe dermatological drugs market, 2018-2030 (US$M)
Related Markets
Europe dermatological drugs market highlights
- The Europe dermatological drugs market generated a revenue of USD 6,787.1 million in 2024.
- The market is expected to grow at a CAGR of 9.1% from 2025 to 2030.
- In terms of segment, psoriasis was the largest revenue generating therapy in 2024.
- Psoriasis is the most lucrative therapy segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2025 to 2030.
Europe data book summary
| Market revenue in 2024 | USD 6,787.1 million |
| Market revenue in 2030 | USD 11,437.2 million |
| Growth rate | 9.1% (CAGR from 2025 to 2030) |
| Largest segment | Psoriasis |
| Fastest growing segment | Psoriasis |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Acne, Psoriasis, Rosacea, Alopecia |
Other key industry trends
- In terms of revenue, Europe region accounted for 28.4% of the global dermatological drugs market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 11,428.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Dermatological Drugs Market Scope
Dermatological Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe dermatological drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dermatological drugs market will help companies and investors design strategic landscapes.
Psoriasis was the largest segment with a revenue share of 39.27% in 2024. Horizon Databook has segmented the Europe dermatological drugs market based on acne, psoriasis, rosacea, alopecia covering the revenue growth of each sub-segment from 2018 to 2030.
The dermatological drugs market in Europe is experiencing growth, driven by the increasing prevalence of skin conditions such as eczema, psoriasis, and acne. Well-established healthcare systems and the growing demand for therapeutic and aesthetic dermatological treatments support the market. The development of advanced drug formulations and innovations in treatment options further contribute to market growth across key European countries.
Key drivers in the European dermatological drugs market include the rise in skin disorders and the aging population, which increases the demand for anti-aging and dermatological treatments. Furthermore, the growing awareness of dermatological conditions, combined with advancements in biologics and other specialized therapies, supports the adoption of new treatments. The increasing availability of telemedicine services enhances access to dermatological care, expanding the market.
Reasons to subscribe to Europe dermatological drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe dermatological drugs market databook
-
Our clientele includes a mix of dermatological drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe dermatological drugs market , including forecasts for subscribers. This continent databook contains high-level insights into Europe dermatological drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe dermatological drugs market size, by country, 2018-2030 (US$M)
Europe Dermatological Drugs Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
